华邦健康：2025年净利润同比预增320.74%至344.16%

Core Viewpoint - Huabang Life Health Co., Ltd. (stock code: 002004) is expected to turn a profit in 2025, significantly improving its performance compared to the previous year [1] Financial Performance Summary - The company forecasts a net profit attributable to shareholders of between 660 million yuan and 730 million yuan for the year 2025, a substantial increase of 320.74% to 344.16% compared to a loss of approximately 298.99 million yuan in the same period last year [1] - The net profit after deducting non-recurring gains and losses is expected to be between 600 million yuan and 670 million yuan, representing a growth of 277.59% to 298.31% from a loss of about 337.85 million yuan in the previous year [1] - Basic earnings per share are projected to be between 0.3345 yuan and 0.3700 yuan, compared to a loss of 0.1514 yuan per share in the same period last year [1] Strategic Initiatives - The company attributes its performance improvement to its strategic focus on "cautious expansion, reduced financing, deep market penetration, and strong barriers," which enhances core competitiveness and operational management across various business segments [1] - The agricultural chemical new materials segment has benefited from a partial industry recovery, with the company actively expanding its market presence and improving efficiency, contributing to the segment's performance enhancement [1] - The pharmaceutical and tourism segments have also shown steady growth, collectively driving significant overall performance improvement [1]